Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biobased Chemicals

EnginZyme raises $22 million for biomanufacturing

by Matt Blois
December 29, 2022 | A version of this story appeared in Volume 101, Issue 1

 

A person at work in an enzyme research lab.
Credit: EnginZyme
EnginZyme operates research labs in Stockholm.

The cell-free biomanufacturing start-up EnginZyme has raised $22 million in series B financing from Bunge Ventures, Sofinnova Partners, and others. The Swedish company aims to replace petrochemical production of plastics, rubber, and other materials with a process that uses enzymes and packed-bed reactors. EnginZyme claims that its process is cheaper and easier to scale up than other biomanufacturing methods. It plans to use the funding to improve the scalability of its technology.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.